This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Durbin, S. A. Search for Related Content Social Bookmarking                         What's this?

The Use of Ultrasound to Identify Fetuses with Down Syndrome

Case Study and Review

Midelfort Clinic Women's Health, 1400 Bellinger Street, Eau Claire, WI 54703.

Karyotyping by invasive prenatal testing such as amniocentesis or chorionic villi sampling is the only definitive method of determining Down syndrome. However, both methods are associated with procedure-related risks. The combination of two noninvasive tools, the maternal serum triple screen and the ultrasound examination, provides a way of identifying fetuses at higher risk for Down syndrome. Ultrasound markers are sonographic findings that may exist as structural malformations or normal variants that are more prevalent in Down syndrome. Depending on the particular marker, either a single marker or a cluster may indicate an increased risk of an affected fetus. Sonographic markers include duodenal atresia, cardiac defects, brachycephaly, mild ventriculomegaly, flattened facial profile, thickened nuchal skin fold, fetal hydrops, hyperechoic bowel, choroid plexus cysts, pyelectasis, shortened extremities, echogenic intracardiac foci, greater iliac wing angle, and specific findings in the fetal hand and foot.

Key Words: Down syndrome • prenatal diagnosis • trisomy 21 • ultrasound

Journal of Diagnostic Medical Sonography, Vol. 15, No. 3, 107-111 (1999)
DOI: 10.1177/875647939901500304


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?